Hospira To Acquire Injectable Drug Business Of India's Orchid Pharmaceuticals

WASHINGTON - Hospira announced Dec. 15 it will purchase Orchid Chemicals & Pharmaceuticals' generic injectable drug business for $400 million, thereby filling one gap in the company's broadening therapeutic coverage